Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...

The full CMI on the next page has more details. If you are worried about taking this medicine, speak to your pharmacist or doctor. 1. Why am I taking CELEBREX RELIEF? CELEBREX RELIEF contains the ...

A new use for a common painkiller. A medication prescribed to treat pain appears to have the power to keep cancer at bay. Celebrex is an anti-inflammatory used to alleviate symptoms of arthritis, ...

Credit: Getty Images. Seglentis is a co-crystal formulation of celecoxib, an NSAID, and tramadol hydrochloride, an opioid agonist and inhibitor of norepinephrine and serotonin reuptake. The Food and ...

Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

WASHINGTON — Take the generic drug clonidine for high blood pressure? Double-check that you didn't leave the drugstore with Klonopin for seizures, or the gout medicine colchicine. Mixing up drug names ...

A second cancer study using the drug found no increased heart risk with patients taking 400 mg of Celebrex per day. The standard recommended dose for Celebrex to treat osteoarthritis arthritis — the ...

NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...

Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for multimodal postoperative pain management. We evaluated opioid-sparing effects and rehabilitative results after ...

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived ...

Pfizer announced Friday that it found the increased risk in one of two long-term cancer-prevention trials, while the other trial showed no increased risk. The company was conducting the trials as part ...